Vutrisiran in Patients with Transthyretin Amyloidosis with CardiomyopathyMarianna Fontana, Mathew S. Maurer, Thibaud Damy et al.|New England Journal of Medicine|2024Cited by 356
Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registryJosé López‐Sendón, Teresa López‐Fernández, Carlos Álvarez-Ortega et al.|European Heart Journal|2020Cited by 282
New cardiac and skeletal protein aggregate myopathy associated with combined MuRF1 and MuRF3 mutationsMontse Olivé, Homa Tajsharghi, Saba Abdul-Hussein et al.|Human Molecular Genetics|2015Cited by 62